Innovative Research Environment: We have established a dynamic and stimulating research environment that effectively addresses societal needs through innovative technical solutions, underpinned by solid management and scientific rigor. Our proactive investment in research and development not only fosters innovation but also ensures rapid integration of cutting-edge technologies into our operations.

Diverse Expert Team: Our R&D center employs over 100 skilled professionals, including Pharmaceutical Chemistry Experts, Pharmaceutical Technologists, Patent Attorneys, Pharmacologists, and Analytical Chemists, all of whom hold advanced degrees. This diverse team works collaboratively on a variety of formulations and drug delivery systems.

Broad Product Development: CAISA Pharma International’s R&D initiatives have yielded a wide array of dosage forms, including solid, liquid, semi-solid, and inhalable products. Each formulation is developed to ensure efficacy, safety, and stability, meeting the rigorous standards required in today’s competitive pharmaceutical landscape.

Continual Learning and Development: We are committed to the ongoing professional and personal development of our R&D staff, fostering a culture of learning and knowledge sharing that benefits not just our company but the broader global community. Each project enhances our collective expertise, contributing to our overarching goal of continuous improvement.

Global Compliance and Innovation: Our development processes adhere to international guidelines, such as those set by the FDA, EMEA, WHO, and ICH, supporting our extensive export activities across more than 70 countries. Our R&D center is integral to maintaining our compliance and competitiveness on the global stage.

Comprehensive R&D Operations: The CAISA Pharma International R&D center encompasses several specialized groups, including patent, active ingredient research, new product formulation, analytical development, clinical research, project management, product improvement, and new product stability. Employing a Quality by Design (QbD) approach, we conduct extensive patent screenings, active substance characterizations, formulation developments, and stability studies.

Fostering Innovation Culture: A pivotal aspect of our R&D strategy is nurturing an innovation culture within our organization and extending it through collaborations with universities, industry partners, and national research initiatives like TÜBİTAK. These partnerships enhance our ability to innovate and respond effectively to the ever-evolving needs of the healthcare sector.

At CAISA Pharma International, our research and development are not just about creating drugs but are a cornerstone of our mission to innovate responsibly and improve health outcomes worldwide.